We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
-16.08%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
AUM
$1.79B
AUM Growth
-$769M
Cap. Flow
-$325M
Cap. Flow %
-18.19%
Top 10 Hldgs %
13.27%
Holding
993
New
75
Increased
285
Reduced
405
Closed
227

Sector Composition

Rank Sector Weight
1 Technology 25.01%
2 Healthcare 13.46%
3 Industrials 11.37%
4 Consumer Discretionary 8%
5 Financials 6.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VAR
26
DELISTED
Varian Medical Systems, Inc.
VAR
$12.4M 0.69%
109,288
-81,686
-43% -$9.34M
NATI
27
DELISTED
National Instruments Corp
NATI
$12.4M 0.69%
272,781
-185,356
-40% -$8.65M
ADSK icon
28
Autodesk
ADSK
$52.6B
$12.4M 0.69%
96,180
-37,984
-28% -$5.13M
QGEN icon
29
Qiagen
QGEN
$8.72B
$12.4M 0.69%
338,393
-155,834
-32% -$5.79M
XLNX
30
DELISTED
Xilinx Inc
XLNX
$12.3M 0.69%
144,262
-114,447
-44% -$9.57M
ILMN icon
31
Illumina
ILMN
$28.4B
$12.3M 0.69%
42,060
-19,727
-32% -$6.11M
ABB
32
DELISTED
ABB Ltd
ABB
$12.2M 0.69%
+645,340
New +$13.1M
JBTM
33
JBT Marel
JBTM
$6.39B
$12.2M 0.68%
169,629
+3,192
+2% +$283K
RAVN
34
DELISTED
Raven Industries Inc
RAVN
$12.2M 0.68%
336,100
-81,233
-19% -$3.38M
GMED icon
35
Globus Medical
GMED
$11.2B
$11.8M 0.66%
+272,897
New +$13.6M
TRMB icon
36
Trimble
TRMB
$13.9B
$11.7M 0.66%
356,068
-114,755
-24% -$4.22M
APTV icon
37
Aptiv
APTV
$10.3B
$11.7M 0.65%
189,469
-47,365
-20% -$3.43M
AMBA icon
38
Ambarella
AMBA
$3.81B
$11.6M 0.65%
331,056
-183,767
-36% -$6.51M
MANH icon
39
Manhattan Associates
MANH
$11.4B
$11.4M 0.64%
269,788
-69,607
-21% -$3.3M
BEAT
40
DELISTED
BioTelemetry, Inc.
BEAT
$11.4M 0.64%
+191,168
New +$11.5M
SSYS icon
41
Stratasys
SSYS
$774M
$11.2M 0.63%
623,754
-240,849
-28% -$5.03M
DDD icon
42
3D Systems Corp
DDD
$613M
$11.1M 0.62%
1,094,062
+19,256
+2% +$264K
NUAN
43
DELISTED
Nuance Communications, Inc.
NUAN
$11M 0.62%
963,686
-433,528
-31% -$6.07M
MAXR
44
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$10.5M 0.59%
882,111
+280,680
+47% +$5.71M
HLX icon
45
Helix Energy Solutions
HLX
$1.41B
$9.16M 0.51%
1,693,172
-558,497
-25% -$4.55M
GHY
46
PGIM Global High Yield Fund
GHY
$483M
$7.85M 0.44%
607,475
-10,634
-2% -$142K
EVV
47
Eaton Vance Limited Duration Income Fund
EVV
$1.07B
$7.7M 0.43%
645,711
-8,925
-1% -$109K
ISD
48
PGIM High Yield Bond Fund
ISD
$419M
$7.68M 0.43%
589,347
-9,935
-2% -$135K
USA icon
49
Liberty All-Star Equity Fund
USA
$1.85B
$7.55M 0.42%
1,403,295
-19,402
-1% -$115K
ETJ
50
Eaton Vance Risk-Managed Diversified Equity Income Fund
ETJ
$575M
$7.52M 0.42%
926,364
-12,804
-1% -$117K

Similar funds

Vident Investment Advisory's Q4 2018 Portfolio in Review

As of Q4 2018, Vident Investment Advisory held 993 positions worth $1.79B, down 30% from $2.55B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Vident Investment Advisory withdrew a net $325M in Q4 2018, closing 227 positions and reducing 405 holdings. Its most notable exit was Lazard, an estimated $3.82M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Vident Investment Advisory opened a new position in Globus Medical worth $11.8M.

  • Vident Investment Advisory's largest Q4 2018 buy was Globus Medical: 272,897 shares worth $11.8M.
  • Vident Investment Advisory added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $22.8M increase.
  • Vident Investment Advisory's biggest Q4 2018 reduction was Zebra Technologies, cutting an estimated $12.4M.
  • Vident Investment Advisory fully exited Lazard in Q4 2018, selling an estimated $3.82M.
  • Vident Investment Advisory's ten largest holdings make up 13% of its $1.79B portfolio in Q4 2018.
  • Vident Investment Advisory opened 75 new positions and closed 227 in Q4 2018.
  • Vident Investment Advisory's portfolio value fell 30% quarter-over-quarter to $1.79B.

Based on Vident Investment Advisory's 13F filing for Q4 2018, filed 14 Feb 2019.